Q1FY23 Quarterly Result Announced for Tarsons Products Ltd.
Plastic products firm Tarsons Products announced Q1FY23 Result : Q1FY22 i.e. April to June 2021 witnessed higher share of sales on account of second wave of Covid. The Revenue contribution from conventional business in Q1FY22 was lower due to the demand from other life science industry on account of lockdowns and reduced activities. Q1FY23 witnessed a normalized quarter with healthy growth and higher contribution from conventional business. On a like-to-like basis, our conventional business has witnessed YoY growth. Gross margin in Q1FY23 was impacted due to change in product mix and inflationary commodity environment on account of geo political tensions and supply chain disruptions. EBIDTA margins in Q1FY23 were also impacted on account of higher expenses due to traveling and participation in fare & exhibitions and higher investments in manpower to support future growth. Commenting on the Q1 FY23 performance of the company Mr. Rohan Sehgal Said: “Revenue for Q1FY23 was muted on account of higher share of Covid related revenues which contributed significantly in Q1FY22. However, despite negligible contribution from covid related revenues in Q1FY23 your company has been able to deliver revenues at par on Y-o-Y basis. We have been participating in various fare & exhibitions in the exports markets to mark our presence as a leading suppliers of labware products of global standards and quality. We have been receiving positives responses & enquires and are optimistic of higher demand from international markets going forward. Our expansion of new facilities is on track and progressing well, we believe with the new facilities, addition of new product portfolio and trusted brand for “TARSONS” in the life science community, we are optimistic about the new phase of growth of your company. Our focus remains on brand building, deliver quality products, automation of processes and improve export presence and we continue to work in that direction.” Result PDF08-08-2022